Kyowa Kirin Holdings B.V.
3 products tracked · names used in filings: Kyowa Kirin Holdings B.V.
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Nouryant istradefylline | Refused | |
| 🇪🇺 | Poteligeo mogamulizumab | Authorised | 2018-11-22 |
| 🇪🇺 | Crysvita burosumab | Authorised | 2018-02-19 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.